gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
Clinical utility of comprehensive genomic profiling and targeted therapy in bili
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
The pattern of mucin 5AC (MUC5AC) expression using immunohistochemistry and its
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
The prevalence of targetable genomic alterations is substantially high in rare t
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
HBV-human DNA integration in non-hepatic tumors.
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Immunohistochemistry analyses of LAG-3 expression across different tumor types a
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mu
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Impact of immunotherapy use in patients with stage IV biliary carcinoma.
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Phase I study of rucaparib and irinotecan in advanced solid tumors with homologo
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every t
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Pilot study on outcome and antitumor efficacy of an autologous cancer cell vacci
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb;
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Clinical utility of comprehensive genomic profiling and targeted therapy in bili